Abstract
Background and Aims : SARS-CoV-2 positive patients show high frequency of thromboembolic complications. Comorbidities like ischemic heart disease (IHD) associate with worse outcome. Since lipoprotein(a) [Lp(a)] is a strong risk factor for IHD and has possibly thrombogenic properties, we investigated in UK Biobank whether SARS-CoV-2 infections alter the Lp(a)-driven risk for IHD and thromboembolic events.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
